Unique ID issued by UMIN | UMIN000029232 |
---|---|
Receipt number | R000033339 |
Scientific Title | Effects of Digoxin on Rosuvastatin Pharmacokinetics in Healthy Volunteers |
Date of disclosure of the study information | 2017/10/01 |
Last modified on | 2019/03/06 11:51:55 |
Effects of Digoxin on Rosuvastatin Pharmacokinetics in Healthy Volunteers
Effects of Digoxin on Rosuvastatin Pharmacokinetics in Healthy Volunteers
Effects of Digoxin on Rosuvastatin Pharmacokinetics in Healthy Volunteers
Effects of Digoxin on Rosuvastatin Pharmacokinetics in Healthy Volunteers
Japan |
Healthy volunteers
Adult |
Others
NO
Evaluating the efficacy and safety of digoxin on rosuvastatin pharmacokinetics at a single-center open-label study in Japanese healthy male volunteers.
Safety,Efficacy
Confirmatory
Explanatory
Phase I
Compared between a rosuvastatin alone and rosuvastatin with digoxin by means of the geometric mean ratio (GMR) AUC (0-last) and its 90% confidence interval (CI).
1) Cmax and GMR (AUC (0-inf)) and its 90% CI
2) Pharmacokinetic parameter (Cmax, tmax, t1/2, AUC0-inf, AUC0-last, CL/F, Vd/F)
3) Plasma concentration of rosuvastatin in transition
Interventional
Cross-over
Non-randomized
Open -no one is blinded
Active
2
Diagnosis
Medicine |
Rosuvastatin 5mg is administered once on Day 1 of Phase 1 and Day 1 of Phase 2 Study
Digoxin 0,25mg on Day 1 of the Phase 2 study.
20 | years-old | <= |
45 | years-old | > |
Male
1) Subjects who are aged between 20 and 45 (exclusive) years old, at the time of Informed Consent.
2) Subjects who have a BMI (Body Mass Index) between 18.5 and 28.0 (exclusive).
1) Have a history of drug abuse or alcohol addiction or a history of allergies to any medication.
2) Have a history of hypersensitivity to rosuvastatin or digoxin .
3) Have a disease which may affect drug evaluation, a history of invasive therapy or radiation therapy.
4) Have taken the drugs, foods or drinks containing methylxanthine such as caffeine (coffee, tea, cola drinks, chocolate, etc) for 48 hours before testing.
5) Have taken any foods or drinks containing grapefruit juice, grapefruit, St. John's wort or Seville orange for 48 hours before testing.
6) Smoke (including those who take nicotine - containing products). However, those who stop smoking (unused period of nicotine-containing products) over 24 weeks are excluded.
7) Drink any beverage containing alcohol for 1 weeks before testing.
8) Conducted intense exercise or hard labor (more than 1 day a day for more than 5 days a week).
9) Have a history of drug abuse or alcohol addiction.
10) Use any medical drugs for 4 weeks before testing.
11) Treated with OTC, nutrients, vitamins, herbal preparations (including traditional Chinese medicine) for 1 weeks before testing.
12) Subjects are not currently enrolled in a clinical trial involving an investigational drug or device, or had not been enrolled in any other medical research for 16 weeks before testing.
13) Fall under any of the following:
a) Received blood transfusion within 12 weeks before testing.
b) Donated more than 400 mL of blood within 12 weeks before testing.
c) Donated more than 200 mL of blood within 4 weeks before testing.
d) Donated component blood donation within 2 weeks before testing.
14) Have a history of infectious diseases requiring urgent treatment.
15) Have a positive result for Human Immunodeficiency Virus (HIV) test, hepatitis B or C antigen test or syphilis test.
16) Subjects determined by the investigators to be inadequate for inclusion in this study for any other reasons.
10
1st name | |
Middle name | |
Last name | Naoto Uemura |
Oita University Hospital
Clinical Pharmacology Center
1-1 Idaigaoka, Hasama, Yufu-city, Oita, JAPAN
097-586-5952
uemura@oita-u.ac.jp
1st name | |
Middle name | |
Last name | Naoto Uemura |
Oita University Hospital
Clinical Pharmacology Center
1-1 Idaigaoka, Hasama, Yufu-city, Oita, JAPAN
097-586-5952
uemura@oita-u.ac.jp
Dept of Clinical Pharmacology and Therapeutics, Oita University Faculty of Medicine
Seren Pharmaceuticals Inc.
Profit organization
Sato Pharmaceutical Co.
NO
2017 | Year | 10 | Month | 01 | Day |
Unpublished
Completed
2019 | Year | 07 | Month | 11 | Day |
2019 | Year | 10 | Month | 01 | Day |
2017 | Year | 09 | Month | 21 | Day |
2019 | Year | 03 | Month | 06 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033339
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |